What is the evidence for immune dysfunction in long COVID?
The strongest evidence comes from large, multi-omic studies that track immune changes over time. One landmark study of 309 COVID-19 patients from diagnosis through convalescence identified four factors at the time of initial infection that predicted long COVID: type 2 diabetes, detectable SARS-CoV-2 virus in the blood (RNAemia), reactivation of Epstein-Barr virus, and the presence of specific auto-antibodies [5]. This suggests the immune system's early response sets the stage for chronic problems.
Further supporting this, a proteomic analysis of 42 long COVID patients (compared to 21 healthy controls) found that over 200 out of 700 measured cardiometabolic proteins were dysregulated, with more than 90% being upregulated [3]. This points to a broad, persistent activation of immune and inflammatory pathways. Another study of 120 post-COVID individuals found significantly elevated levels of inflammatory markers like IL-6 and TNF-α, along with reduced percentages of regulatory T cells (Tregs), which normally help calm the immune response [6]. This combination of high inflammation and low immune regulation is a hallmark of immune dysfunction.
Does this immune dysfunction affect specific body systems?
Yes, the immune disruption appears to have widespread effects, particularly on the cardiovascular and nervous systems. A study of 92 long COVID patients found that 41% had microvascular endothelial dysfunction—damage to the lining of small blood vessels—an average of 31 months after their initial infection [2]. This was linked to rising levels of NT-proBNP, a marker of heart strain, suggesting a direct connection between ongoing immune/inflammatory activity and cardiovascular problems.
The immune system also seems to target the nervous system. In a study of 48 patients with persistent loss of smell after COVID, brain scans showed reduced gray matter volume in areas related to smell and emotion (like the amygdala and insula) and increased water diffusion in white matter tracts, indicating ongoing inflammation or damage [7]. This is consistent with the idea that immune cells or inflammatory molecules are directly affecting brain tissue. Furthermore, a review notes that autonomic nervous system dysfunction, including postural orthostatic tachycardia syndrome (POTS), occurs in about 30% of long COVID patients, which is often driven by autoimmune processes [8].
How long does the immune dysfunction last, and can it be measured?
The immune changes are not just a short-term blip; they can persist for years. One study found that endothelial dysfunction (blood vessel lining damage) was still detectable an average of 31 months after the initial infection [2]. Another study showed that men had low testosterone levels (a sign of hormonal disruption linked to immune function) 77 days after illness onset, and this was associated with a lower quality of life [4].
These changes can be measured with standard lab tests. For example, elevated C-reactive protein (CRP) at hospital admission was an independent predictor of persistent shortness of breath five months later [1]. High levels of inflammatory cytokines like IL-6 and TNF-α, along with oxidative stress markers like MDA, are also commonly found in long COVID patients [6]. Even mitochondrial function in platelets is impaired, and this can be measured with high-resolution respirometry [9]. These measurable biomarkers confirm that the immune system is not simply 'recovering' but is stuck in a dysfunctional, overactive state.
About These Sources
This answer is built on 9 peer-reviewed studies — published from 2022 to 2025, 2 from 2024 or later, 3 in Q1 journals, collectively cited 1,270 times — selected as the most relevant from 15 studies that passed quality screening, drawn from 49 papers retrieved from a database of over 500 million.
Sources used in this answer
Dyspnea in Post-Acute COVID-19: A Multi-Parametric Cardiopulmonary Evaluation
In 225 patients, higher C-reactive protein (CRP) at hospital admission and longer hospitalization predicted persistent dyspnea 5 months later, linking initial inflammation to long-term symptoms.
Post-Acute COVID-19 Syndrome: Prevalence of Peripheral Microvascular Endothelial Dysfunction and Associations With NT-ProBNP Dynamics.
In 92 long COVID patients, 41% had microvascular endothelial dysfunction (damage to small blood vessels) an average of 31 months after infection, which was linked to rising heart strain markers (NT-proBNP).
Dysregulations in hemostasis, metabolism, immune response, and angiogenesis in post-acute COVID-19 syndrome with and without postural orthostatic tachycardia syndrome: a multi-omic profiling study.
In 42 long COVID patients vs. 21 controls, over 200 of 700 measured cardiometabolic proteins were dysregulated (mostly upregulated), along with 11 of 33 cytokines/chemokines, indicating broad, persistent immune activation 18 months post-infection.
Male pituitary-gonadal axis dysfunction in post-acute COVID-19 syndrome-Prevalence and associated factors: A Mediterranean case series.
In 143 male COVID-19 survivors, 28.7% had low testosterone and 18.1% had impaired Sertoli cell function 77 days after illness, indicating lasting hormonal/immune disruption.
Multiple early factors anticipate post-acute COVID-19 sequelae
In a multi-omic study of 309 patients, four factors at initial diagnosis (type 2 diabetes, SARS-CoV-2 RNAemia, EBV viremia, and specific auto-antibodies) predicted long COVID, showing early immune dysfunction sets the stage.
Post-Acute COVID-19 Pathophysiology: Cellular Stress Responses, Immune Dysregulation, and Biochemical Signatures in Recovery Phase.
In 120 post-COVID individuals, significant elevations in ER stress markers, inflammatory cytokines (IL-6, TNF-α), and oxidative stress markers were found, along with reduced regulatory T cells, indicating ongoing immune and cellular stress.
Structural brain changes in post‐acute COVID‐19 patients with persistent olfactory dysfunction
In 48 patients with persistent smell loss, brain scans showed reduced gray matter volume in olfactory-related regions and increased water diffusion (a sign of inflammation) in white matter tracts, linking immune activity to brain changes.
Autonomic dysfunction and postural orthostatic tachycardia syndrome in post-acute COVID-19 syndrome
A review reports that postural orthostatic tachycardia syndrome (POTS), a form of autonomic dysfunction often driven by autoimmunity, occurs in 30% of long COVID patients.
Effect of Vaccination on Platelet Mitochondrial Bioenergy Function of Patients with Post-Acute COVID-19
In a study of 20 post-acute COVID-19 patients, unvaccinated individuals had reduced platelet mitochondrial function compared to vaccinated individuals, showing that vaccination may protect against some aspects of cellular immune dysfunction.